Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Healthcare Advertising Agencies
Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Mydecine Innovations Group Inc
Bullboard Posts
User Avatar Image
(5)
•••
Comment by GGORI94on Mar 29, 2017 5:51pm
86 Views
Post# 26048880

RE:.12 TOMORROW CLOSE

RE:.12 TOMORROW CLOSEHello again Triple777, nice operation you have going here again. Loser, loser.

C.UMB

.03 TOMORROW

0 stars
 
 

See what shakes down. BAD INVESTMENT 

3 minutes ago
C.NF

.12 TOMORROW CLOSE

0 stars
 
 

YAH BABY

9 minutes ago
C.VP

SEll sell people bailing

0 stars
 
 

WORTH .02 ON A GOOD DAY

19 minutes ago
C.N

Dr N SAYS KEEP SELLING CHEAP SHARES

0 stars
 
 

.20

32 minutes ago
C.N

I Love it .20 Tomorrow

5 stars
 
 

Down she goes

1 hour ago
C.N

SEll sell people bailing

0 stars
 
 

Everyone panicking right on 

2 hours ago
C.N

RE:RE:RE:RE:RE:topped up

0 stars
 
 

Perfect some sucker just sold me more at 26 keep selling need more

2 hours ago
 

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities